Coya Therapeutics Inc (COYA)
CoyaTherapeutics - Coya Therapeutics Announces Proposed Public Offering of Common Stock
Eton Pharmaceuticals Inc. (ETON)
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Coya Therapeutics Inc (COYA)
Coya Therapeutics Announces Proposed Public Offering of Common Stock
Travere Therapeutics, Inc (TVTX)
Travere Therapeutics to Report Third Quarter 2025 Financial Results
Myovant Sciences Ltd. (the company became a subdivision of the company Sumitomo Pharma America, Inc. (SMPA)) (MYOV)
Community Health Systems, Inc. Announces Third Quarter Ended September 30, 2025 Results
Community Health Systems (CYH)
Community Health Systems, Inc. Announces Third Quarter Ended September 30, 2025 Results
Qualigen Therapeutics Inc. (QLGN)
Qualigen Therapeutics, Inc Notification (QLGN)
Puma Biotechnology Inc (PBYI)
Puma Biotechnology, Inc. - Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
Artivion Inc (AORT)
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
Inovio Pharmaceuticals Inc (INO)
Inovio - INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
Caredx Inc (CDNA)
CareDx - CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
Puma Biotechnology Inc (PBYI)
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
Revvity Inc. (RVTY)
Revvity - Revvity Board Declares Quarterly Dividend
CorMedix Inc. (CRMD)
Notification from CorMedix Inc.
Iovance Biotherapeutics Inc (IOVA)
Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025